PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation
Authors
Keywords
PIM1, c-Myc, IL-6, EMT, Breast cancer
Journal
Breast Cancer
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-04-15
DOI
10.1007/s12282-019-00966-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pim1 supports human colorectal cancer growth during glucose deprivation by enhancing the Warburg effect
- (2018) Meng Zhang et al. CANCER SCIENCE
- PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis
- (2018) Bin Zhao et al. Cell Death & Disease
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer
- (2018) Michitaka Nakano et al. ONCOGENE
- PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia
- (2017) Hui Cheng et al. Journal of Translational Medicine
- EMT programs promote basal mammary stem cell and tumor-initiating cell stemness by inducing primary ciliogenesis and Hedgehog signaling
- (2017) Vincent J. Guen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma
- (2016) Zhen Rang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma
- (2016) Danni Deng et al. CANCER SCIENCE
- PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value
- (2016) Jianwei Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
- (2016) Dai Horiuchi et al. NATURE MEDICINE
- PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer
- (2016) Fara Brasó-Maristany et al. NATURE MEDICINE
- USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells
- (2016) Yu Qian et al. Scientific Reports
- Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial–mesenchymal transition
- (2015) Hong Liu et al. CARCINOGENESIS
- A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
- (2015) Elvin Wagenblast et al. NATURE
- Inflammation and cancer: advances and new agents
- (2015) Shanthini M. Crusz et al. Nature Reviews Clinical Oncology
- Versatile functions for IL-6 in metabolism and cancer
- (2015) Jan Mauer et al. TRENDS IN IMMUNOLOGY
- PIM-1 modulates cellular senescence and links IL-6 signaling to heterochromatin formation
- (2015) Bo Jin et al. AGING CELL
- PIM1 Kinase Phosphorylates the Human Transcription Factor FOXP3 at Serine 422 to Negatively Regulate Its Activity under Inflammation
- (2014) Zhiyuan Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pim-1 kinase is a target of miR-486-5p and eukaryotic translation initiation factor 4E, and plays a critical role in lung cancer
- (2014) Wenshuai Pang et al. Molecular Cancer
- Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction
- (2013) T Nagasaki et al. BRITISH JOURNAL OF CANCER
- Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
- (2013) Z. C. Hartman et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2
- (2013) Tracy X. Cui et al. IMMUNITY
- Expression of pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients
- (2013) Yong-hai Peng et al. PLoS One
- TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma
- (2012) Pengyuan Yang et al. CANCER CELL
- Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors
- (2012) Marjo Malinen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation
- (2012) Yijing Li et al. Molecular Cancer
- Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
- (2010) N Turner et al. ONCOGENE
- Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
- (2010) J Wang et al. ONCOGENE
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
- (2009) N J Sullivan et al. ONCOGENE
- Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels
- (2008) D. Morishita et al. CANCER RESEARCH
- Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
- (2008) Anne-Pierre Morel et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started